BioCryst Pharmaceuticals Inc (BCRX): Capital Expenditures
$2.47M
Year ended 2025-12-31
$2.76M
Trailing 12 months to 2026-06-30
+22.2%
3-year compound annual growth
+36.9%
5-year compound annual growth
-7.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.47M | +119.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.12M | -48.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.17M | +60.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $1.35M | -43.4% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $2.38M | +364.0% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $514.0K | +49.9% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $343.0K | -6.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $366.0K | +11.6% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $328.0K | -93.8% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $5.28M | +3.0% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $5.12M | n/m | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | $106.0K | +253.3% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $30.0K | -73.5% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $113.0K | +105.5% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $55.0K | -83.1% | 2014-03-10, From 2011-01-01 |
| 2010-12-31 | $325.0K | -46.2% | 2013-03-11, From 2010-01-01 |
| 2009-12-31 | $604.0K | n/a | 2012-03-06, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $2.47M | +119.6% |
| Repligen Corp (RGEN) | 2025-12-31 | $23.52M | -8.4% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $28.85M | -7.0% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $6.97M | -34.8% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $22.57M | +174.4% |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | $9.86M | +529.2% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $4.34M | -16.1% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $192.00M | -81.7% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $11.95M | +182.0% |
Compare BCRX, RGEN, TECH, HALO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗